Food and Drug Administration(FDA)

Digital case/grant/service workflows, interoperable data, risk-based oversight, and shared services where the parent department can supply them without erasing mission expertise.

Identify who is forced to learn this bureau's rules: beneficiaries, applicants, regulated entities, grantees, state partners, researchers, or frontline staff. Reduce that burden through reusable evidence and clearer status information.

Coordinate with sibling bureaus before proposing consolidation. Some overlap is useful when it supplies checks, field presence, or resilience.

Do not cut mission-critical inspectors, adjudicators, scientists, field staff, or technical experts before the replacement process has proved it can preserve accuracy and rights.

Improve FDA through Review workflow modernization, postmarket evidence systems, supply-chain data, and faster guidance without compromising safety standards.